CHF Solutions Inc (NASDAQ:CHFS) has been given a consensus broker rating score of 1.00 (Strong Buy) from the two brokers that cover the company, Zacks Investment Research reports. Two research analysts have rated the stock with a strong buy recommendation.

Brokers have set a twelve-month consensus price objective of $3.15 for the company and are expecting that the company will post ($0.59) EPS for the current quarter, according to Zacks. Zacks has also given CHF Solutions an industry rank of 79 out of 255 based on the ratings given to related companies.

Several equities analysts recently commented on the company. Zacks Investment Research upgraded CHF Solutions from a “hold” rating to a “buy” rating and set a $1.25 price objective on the stock in a research note on Tuesday. Dawson James initiated coverage on CHF Solutions in a research note on Tuesday, August 28th. They issued a “buy” rating and a $3.30 price objective on the stock. Finally, ValuEngine upgraded CHF Solutions from a “hold” rating to a “buy” rating in a research report on Monday, July 2nd.

CHF Solutions stock opened at $1.20 on Thursday. CHF Solutions has a 12 month low of $0.93 and a 12 month high of $24.45. The company has a market capitalization of $8.35 million, a P/E ratio of -0.03 and a beta of 2.33.

CHF Solutions (NASDAQ:CHFS) last posted its quarterly earnings data on Tuesday, August 7th. The company reported ($0.93) EPS for the quarter, missing the consensus estimate of ($0.92) by ($0.01). CHF Solutions had a negative net margin of 471.94% and a negative return on equity of 166.88%. The firm had revenue of $1.10 million during the quarter. As a group, equities analysts expect that CHF Solutions will post -2.9 EPS for the current year.

A hedge fund recently bought a new stake in CHF Solutions stock. Perkins Capital Management Inc. bought a new position in shares of CHF Solutions Inc (NASDAQ:CHFS) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 58,962 shares of the company’s stock, valued at approximately $108,000. Perkins Capital Management Inc. owned approximately 0.88% of CHF Solutions at the end of the most recent reporting period. Institutional investors own 20.58% of the company’s stock.

About CHF Solutions

CHF Solutions, Inc, an early-stage medical device company, develops cardiac and coronary disease products primarily in the United States. The company focuses on commercializing the Aquadex FlexFlow system, which is indicated for temporary ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy, and extended ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization.

Further Reading: Treasury Bonds

Get a free copy of the Zacks research report on CHF Solutions (CHFS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for CHF Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CHF Solutions and related companies with MarketBeat.com's FREE daily email newsletter.